Premium
Deep brain stimulation in Lesch–Nyhan disease: outcomes from the patient’s perspective
Author(s) -
Visser Jasper E,
Cotton Adam C,
Schretlen David J,
Bloch Jocelyne,
Tedroff Kristina,
Schechtmann Gastón,
Radu Djurfeldt Diana,
Gonzalez Victoria,
Cif Laura,
Jinnah Hyder A
Publication year - 2021
Publication title -
developmental medicine and child neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.658
H-Index - 143
eISSN - 1469-8749
pISSN - 0012-1622
DOI - 10.1111/dmcn.14852
Subject(s) - deep brain stimulation , adverse effect , psychology , disease , movement disorders , medicine , physical medicine and rehabilitation , parkinson's disease
AIM To provide insight into outcome and long‐term safety and efficacy of deep brain stimulation (DBS), from the perspective of individuals with Lesch–Nyhan disease (LND) and their families. METHOD We used patient‐centered outcome measures to assess long‐term outcomes of DBS for 14 individuals (mean [SD] age 10y 10mo [5y 6mo], range 5–23y, all males) with LND, after an average duration of 5y 6mo (range 11mo–10y 5mo) after surgery. We compared these results with a comprehensive review of previously published cases. RESULTS Patients and their families reported that DBS of the globus pallidus can be effective both for motor and behavioral disturbances in LND. However, outcome measures were often not significantly changed owing to substantial variability among individuals, and were overall less positive than in previous reports based on clinician assessments. In addition, there was an unexpectedly high rate of adverse events, tempering overall enthusiasm for the procedure. INTERPRETATION Although DBS might be an effective treatment for LND, more research is needed to understand the reasons for response variability and the unusually high rates of adverse events before DBS can be recommended for these patients.What this paper adds Individuals with Lesch–Nyhan disease and their families report variable efficacy of deep brain stimulation. Long‐term outcomes are associated with a high adverse event rate.